ON THE PHENOTYPE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- Autores: Ovcharenko S.I.1, Ovcharenko SI1
-
Afiliações:
- Edição: Nº 4 (2011)
- Páginas: 44-46
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278813
- ID: 278813
Citar
Texto integral
Resumo
Chronic obstructive pulmonary disease (COPD) is characterized by considerable heterogeneity of clinical presentation and progression of the disease. Current diagnostic indicators (in particular, forced expiratory volume in first second) can not fully describe this heterogeneity; therefore, introduction of concept of COPD phenotype is necessary. Identification of individual COPD phenotypes not only explain the different course of the disease, but help in selection the most appropriate therapy for each patient, that in turn will improve the quality of life and prognosis in patients with COPD.
Bibliografia
- Хроническая обструктивная болезнь легких (Федеральная программа). Практическое руководство для врачей. Издание 2-е переработанное и дополненное / Под ред. академика РАМН А.Г. Чучалина. М., 2004.
- Buist AS, McBurnie, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
- Celli BR, MacNee W, Agusti AG, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
- Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-55.
- Социально-экономическое бремя бронхиальной астмы и хронической обструктивной болезни легких в Российской Федерацию РРОФ "Качество жизни" НИИ КЭФФ, М., 2009.
- Committee for proprietary medicinal products points to consider on clinical investigation of medicine products in the chronic treatment of patients with COPD. London, CPMP / EWP/ 1999;562-98.
- Jones PW, Agusti A. Outcomes and markers of chronic obstructive pulmonary disease. Eur Resp J 2006;27:822-32.
- Cazzola M, MacNee W, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Resp J 2008;31:416-69.
- Han MeiLan K, Agusti A, Calverely P, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182(5):598-604.
- Хроническая обструктивная болезнь легких / Под ред. А.Г. Чучалина. M., 2008. C. 568.
- Овчаренко С.И., Капустина В.А. Хроническая обструктивная болезнь легких: особенности у женщин // Пульмонология 2009. № 2. C. 102-12.
- Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-point (ECLIPSE). Eur Respir J 2008;31:869-73.
- Agusti A, Calverely P, Celli B, et al. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Research 2010;11:122.
Arquivos suplementares
